Monica Shaw
Director/Miembro de la Junta en AC IMMUNE SA .
Fortuna: 20 954 $ al 30/04/2024
Perfil
Monica Shaw is currently an Independent Non-Executive Director at AC Immune SA, a Senior Vice President-Major Markets at Bristol Myers Squibb Co., and the EVP-Head Region Europe, Canada & Australia at LEO Pharma.
A.
She is also a Member of The Royal College of Physicians and the VP-Commercial & Head-Asia Pacific Region at ViiV Healthcare Co. In the past, she was the Chief Executive Officer at Oncopeptides AB and the Medical Director & Chief Scientific Officer-UK at Novartis AG.
Dr. Shaw received a doctorate degree from Oxford University Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AC IMMUNE SA
0.01% | 01/03/2024 | 9 150 ( 0.01% ) | 20 954 $ | 30/04/2024 |
Cargos activos de Monica Shaw
| Empresas | Cargo | Inicio |
|---|---|---|
| AC IMMUNE SA | Director/Miembro de la Junta | 29/10/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 06/09/2023 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| ViiV Healthcare Co. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Monica Shaw.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOPEPTIDES AB | Director Ejecutivo | 07/08/2023 |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Director Técnico/Científico/I+D | - |
Formación de Monica Shaw.
| Oxford University Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AC IMMUNE SA | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Empresas privadas | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
| ViiV Healthcare Co. | |
| Novartis AG /U.S. Biologics Manufacturing Operation/ | Health Technology |
- Bolsa de valores
- Insiders
- Monica Shaw
